🔎 Trials Near Me

Akèy › Kansè kolon › Virginia › Arlington

Etid klinik pou Kansè kolon nan Arlington, VA

15 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Ap rekriteFaz 1/2
  • NEXT Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07529808

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Ap rekriteFaz 3
  • Virginia Cancer Specialists, PC ( Site 0069), Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997497

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Ap rekriteFaz 1
  • ALX Center 2, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • PHN-012-001 Site, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ap rekriteFaz 3
  • Virginia Cancer Specialists, PC, Arlington
  • Virginia Cancer Specialists, PC, Fairfax · 11 mi lwen
  • Virginia Cancer Specialists, PC, Reston · 14 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Ap rekriteFaz 1/2
  • Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Ap rekrite
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi lwen
  • Kaiser Permanente-Burke Medical Center, Burke · 11 mi lwen
Laj 45 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Ap rekriteFaz 2/3
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi lwen
  • Kaiser Permanente-Burke Medical Center, Burke · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Ap rekriteFaz 1
  • NEXT Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Ap rekriteFaz 1
  • Research Site, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • NEXT Oncology Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • Next Oncology Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Ap rekriteFaz 1/2
  • NEXT, Virginia, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT07145255

Etid Kansè kolon nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.